Curcumin offers numerous benefits to human health, however these benefits cannot be fully utilized due to its challenges with absorption in the body
Hydrocurc® is an award-winning curcumin specifically designed to increase bioavailability of curcuminoids in the body. This is done so by the specifically designed curcumin particles in Hydrocurc® to freely disperse in water
A published pharmacokinetic study on humans demonstrated Hydrocurc® to provide the highest amount of curcuminoids seen in industry to date from a single dose.
Hydrocurc® is a trademark of Pharmako Biotechnologies Pty Ltd.
Increased bioavailability in HydroCurc® can be attributed to a new dispersion technology, LipiSperse®. LipiSperse® is a novel system tailored to increase the dispersion of crystalline lipophilic agents in aqueous environments. Cold water dispersible (CWD) powders have an equilibrium established between the LipiSperse® on the powder surface and the LipiSperse® in the solution.
A recent pharmacokinetic study on HydroCurc® in humans aimed to compare the pharmacokinetics of a single dose of a commercially available curcumin product with a curcumin-LipiSperse® delivery system.
Hydrocurc® is the most bioavailabile curcumin seen in industry to date, as it provides a CMax of 807 ng/ml from a single dose. Hydrocurc® also had more than double the AUC after 6-h compared to standard curcumin.
500mg Hydrocurc® significantly:
Co-administration of 500mg Hydrocurc® with 18mg iron significantly:
May be an effective ingredient in enhancing cognitive function and reducing adverse effects associated with iron supplementation.